Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

OPC-51803

🥰Excellent
Catalog No. T28257Cas No. 192514-54-8
Alias SOU-003, SOU003, SOU 003, OPC51803, OPC 51803

OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.

OPC-51803

OPC-51803

🥰Excellent
Purity: 100%
Catalog No. T28257Alias SOU-003, SOU003, SOU 003, OPC51803, OPC 51803Cas No. 192514-54-8
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
Pack SizePriceAvailabilityQuantity
1 mg332 €In Stock
5 mg786 €In Stock
10 mg1.073 €In Stock
25 mg1.510 €In Stock
50 mg1.881 €In Stock
100 mg2.375 €In Stock
500 mg4.655 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "OPC-51803"

Select Batch
Purity:100%
ee:98.84%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
Targets&IC50
V1a receptor:819+39 nM(Ki), V2 receptor:189+14 Nm(EC50), V2 receptor:91.9+10.8 nM(Ki), cAMP:189+/-14 nM(EC50)
In vitro
OPC-51803 and dDAVP displaced [(3)H]-AVP binding to human V(2)- and V(1a)-receptors with K(i) values of 91.9+/-10.8 nM (n = 6) and 3.12+/-0.38 nM (n = 6) for V(2)-receptors, and 819+/-39 nM (n = 6) and 41.5+/-9.9 nM (n = 6) for V(1a)-receptors, indicating that OPC-51803 was about nine times more selective for V(2)-receptors, similar to the selectivity of dDAVP.[5]
OPC-51803 concentration-dependently increased cyclic adenosine 3', 5'-monophosphate (cyclic AMP) production in HeLa cells expressing human V(2)-receptors with an EC(50) value of 189+/-14 nM (n = 6).[5]
In vivo
OPC-51803 shows antidiuretic action in dogs. OPC-51803 (0.03 to 0.3 mg/kg; oral) decreased urine volume and increased urinary osmolality in a dose-dependent manner in water-loaded dogs.[4]
OPC-51803 infusions (0.3 and 3 microg x kg(-1) x min(-1); Intravenous ) did not affect renal or systemic hemodynamics in anesthetized dogs.[4]
AliasSOU-003, SOU003, SOU 003, OPC51803, OPC 51803
Chemical Properties
Molecular Weight454
FormulaC26H32ClN3O2
Cas No.192514-54-8
SmilesC(=O)(N1C=2C([C@@H](CC(NC(C)C)=O)CCC1)=CC=CC2)C3=C(Cl)C=C(C=C3)N4CCCC4
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (99.12 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2026 mL11.0132 mL22.0264 mL110.1322 mL
5 mM0.4405 mL2.2026 mL4.4053 mL22.0264 mL
10 mM0.2203 mL1.1013 mL2.2026 mL11.0132 mL
20 mM0.1101 mL0.5507 mL1.1013 mL5.5066 mL
50 mM0.0441 mL0.2203 mL0.4405 mL2.2026 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy OPC-51803 | purchase OPC-51803 | OPC-51803 cost | order OPC-51803 | OPC-51803 chemical structure | OPC-51803 in vivo | OPC-51803 in vitro | OPC-51803 formula | OPC-51803 molecular weight